Astera Labs (ALAB)
Information Technology · Semiconductors / Connectivity Solutions · NASDAQ
Astera Labs provides the essential high-speed connectivity chips and software that enable hyperscale AI and cloud data centers to operate at scale.
What Astera Labs does
Astera Labs designs and delivers semiconductor-based connectivity solutions optimized for cloud and AI infrastructure. Its Intelligent Connectivity Platform combines high-speed, mixed-signal hardware—such as retimers, memory controllers, and switches—with a proprietary software suite called COSMOS to manage data, network, and memory bottlenecks in large-scale data centers.
Themes: AI infrastructure, cloud computing, data center connectivity, CXL (Compute Express Link), memory pooling
Fundamentals
- Price$347.05 as of 2026-10-08 close
- Market cap$60.2B as of 2026-07-31 (share count; price 2026-10-08)
- 1-year return+58.2% 2025-10-08 close $219.36 → 2026-10-08 close $347.05
- P/E170.89 as of 2026-10-08
- Net margin+25.7% FY2025, SEC XBRL
- Gross margin+75.7% FY2025, SEC XBRL
- ROE+16.1% FY2025, SEC XBRL
- Debt / equity0.00 as of 2026-09-03
- Revenue growth (YoY)+98.5% as of 2026-09-03
- Revenue CAGR (3y)+120.2% SEC XBRL
- Beta2.78 as of 2026-09-03
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
How ALAB compares in its sector
- price-to-earnings ratiotop 10% 253 covered Information Technology peers, as of 2026-10-08
- net profit margintop 25% 380 covered Information Technology peers, as of 2026-09-03
- operating margintop 25% 375 covered Information Technology peers, as of 2026-09-03
- gross margintop 25% 311 covered Information Technology peers, as of 2026-09-03
- return on equitytop 25% 370 covered Information Technology peers, as of 2026-09-03
- 3-year revenue CAGRtop 10% 385 covered Information Technology peers
- free cash flow (absolute dollars, latest fiscal year)middle range 382 covered Information Technology peers, as of FY2025
Position among covered Information Technology companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How Astera Labs looks technically
Astera Labs (ALAB) is trading 42.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 94 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 3 trading days ago. It is 30.5% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 42.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +42.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $316.61 | $316.61 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $243.77 | $243.77 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 13 calendar days ago — the swings before that are what the structure reading is measured on | 13 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 94 trading days ago — a "golden cross", a bullish long-term signal | 94 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend) | 19.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30) | 52.8 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($308.34 to $401.74) — its "stochastic" reading is 41 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 41.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 16 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $499.48 | $499.48 |
|---|---|---|
| From the 52-week high | it is 30.5% below its 52-week high (its highest price of the past year) | -30.5% |
| Above the 52-week low | it is 254.5% above its 52-week low (its lowest price of the past year) | +254.5% |
| Below the 52-week high | it is 30.5% below its highest point of the past year | 30.5% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $499.48 (set on 2026-06-30) | $499.48 |
| Given back of the 52-week move | over the past year its closes ranged ($100.27 to $483.02), and it has given back roughly a third of its rise from last year’s low — 36% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $234.23 to $246.48. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 35.5% |
| From the all-time high | it is 30.5% below its all-time high | -30.5% |
| Nearest price level | it is trading 6.7% below a resistance level at $370.18 — a price it turned at twice since 2026-06-26, most recently on 2026-08-04. Since 2024-10-08 it has 11 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +6.7% |
| All-time low | its lowest closing price on record is $36.22 (set on 2024-08-07) | $36.22 |
| Above the all-time low | it is 858.3% above its all-time low | +858.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 59th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $24.67 between its high and its low — about 7.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $24.67 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $254.36 and $416.63 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $254.36 – $335.49 – $416.63 |
| Typical daily range (% of price) | its price moves about 7.1% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 7.1% |
| Stretch from the 200-day average | it is trading 4.2 daily ranges above its 200-day average price (42.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.2 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.62× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 9 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 9 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-08 1.8% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.8% |
|---|---|---|
| Open gap | it gapped 3.5% below the previous close 1 session ago and has not traded back through the level it left behind at 389.8 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -3.5% |
| Gap filled | a 3.8% gap up opened on 2026-10-06 has been "filled" 1 session ago — price traded back through the level the gap left behind, and it took 1 session to close | 1 session ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -10.97% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 19.1 percentage points (the stock gained 20.1% while the market gained 1.0%) | +19.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 15.6 percentage points (the stock lost 11.7% while the market gained 3.8%) | -15.6% |
| vs market, 6 months | over the past 6 months this stock beat the market by 176.7 percentage points (the stock gained 194.1% while the market gained 17.5%) | +176.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 43.2 percentage points (the stock gained 58.2% while the market gained 15.0%) | +43.2% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 21.6% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 39% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $248.90 — a volume-weighted average of daily closes over 189 sessions, not a true tick-by-tick VWAP. | +39.4% |
|---|---|---|
| Vs the average paid since it last reported | the price is 8% above the average price paid since it last reported on 2026-08-04 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $321.16 — a volume-weighted average of daily closes over 47 sessions, not a true tick-by-tick VWAP. | +8.1% |
Price levels it has turned at before
ALAB last closed at $347.05 on 2026-10-08. Since 2024-10-08 it has turned at 11 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $370.18 | Resistance | 6.7% above the last close | turned there twice · 2026-06-26 to 2026-08-04 |
| $263.89 | Support | 24.0% below the last close | turned there three times · 2025-09-18 to 2026-09-03 |
| $231.87 | Support | 33.2% below the last close | turned there twice · 2025-10-06 to 2026-05-06 |
| $200.66 | Support | 42.2% below the last close | turned there twice · 2025-08-13 to 2025-10-31 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Pulled back from the 12-month high · Broke out to a new 20-day high · trendless / choppy (low ADX) · beating the market · Most volatile (6%+ typical daily range) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.81 mean, 1=Strong Buy…5=Strong Sell) — 23 analysts
- Mean price target$389.95 range $190.00 – $500.00; median $425.00
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ALAB
- Consensus EPS estimate$1.19 next reporting period, as of 2026-10-09
- Estimate change, 30 days$0.00 (0.0%) from $1.19, on 2026-09-07, 32-day window
- Readings revised upward0% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High customer concentration with a limited number of end customers driving revenue.","Exposure to political, regulatory, and economic policies, particularly regarding trade restrictions and export controls with respect to China.","Dependence on a limited number of third-party manufacturing and supply chain partners."]
What changed in the latest 10-Q
AI-assisted comparison of ALAB's 10-Q filed 2026-08-05 against the prior one filed 2026-05-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (filed 2026-08-05) covers the three and six months ended June 30, 2026 and includes three- and six-month comparisons to 2025 in the Summary of Financial Highlights.
- Newer filing adds a six-month revenue figure of $700.8 million in the Overview, replacing a three-month revenue figure from the older filing.
- Newer filing adds three-month revenue of $392.4 million compared to $191.9 million for the same period in 2025, a 104% increase.
- Newer filing adds six-month revenue of $700.8 million compared to $351.4 million for the same period in 2025, a 99% increase.
- Newer filing adds gross margin of 73.3% for the three months ended June 30, 2026, compared to 75.8% for the same period in 2025, a decrease of 250 bps.
- Newer filing adds gross margin of 74.6% for the six months ended June 30, 2026, compared to 75.4% for the same period in 2025, a decrease of 80 bps.
- Newer filing adds operating income of $89.2 million and $151.1 million for the three and six months ended June 30, 2026, respectively, compared to $39.8 million and $51.1 million for the same periods in 2025, increases of 124% and 196%.
- Newer filing adds net income of $153.1 million and $233.4 million for the three and six months ended June 30, 2026, respectively, compared to $51.2 million and $83.0 million for the same periods in 2025, increases of 199% and 181%.
- Newer filing adds a six-month revenue table showing $700,761 thousand for 2026 and $351,367 thousand for 2025, a $349,394 thousand increase (99%).
- Newer filing adds cost of revenue, gross profit, and gross margin tables for the six months ended June 30, 2026 and 2025.
- Newer filing adds six-month cost of revenue of $178,053 thousand compared to $86,393 thousand, a $91,660 thousand (106%) increase.
- Newer filing adds six-month gross profit of $522,708 thousand compared to $264,974 thousand, a $257,734 thousand (97%) increase.
- Newer filing attributes the three- and six-month gross margin decreases to a shift in product mix towards lower margin hardware modules and the impact of the Warrants.
- Newer filing adds a reference to Note 9 - Common Stock Warrants for additional discussion of Warrants.
- Newer filing changes the product demand drivers in the revenue discussion to list 'Aries, Scorpio, and Taurus products' rather than 'Scorpio, Aries, and Taurus products' (reordering).
- Removed:
- Older filing (filed 2026-05-06) covers the three months ended March 31, 2026 and includes only three-month comparisons to 2025 in the Summary of Financial Highlights.
- Older filing contained a three-month revenue figure of $308.4 million for the three months ended March 31, 2026 in the Overview; this is removed in the newer filing.
- Older filing contained revenue of $308.4 million compared to $159.4 million for the same period in 2025, a 93% increase; removed in the newer filing.
- Older filing contained gross margin of 76.3% for the three months ended March 31, 2026, compared to 74.9% for the same period in 2025, an increase of 136 bps; removed in the newer filing.
- Older filing contained operating income of $61.8 million for the three months ended March 31, 2026, compared to $11.3 million for the same period in 2025, a 448% increase; removed in the newer filing.
- Older filing contained net income of $80.3 million for the three months ended March 31, 2026, compared to $31.8 million for the same period in 2025, a 152% increase; removed in the newer filing.
- Older filing contained revenue of $308,361 thousand compared to $159,442 thousand, a $148,919 thousand (93%) increase; removed in the newer filing.
- Older filing contained three-month cost of revenue of $73,220 thousand compared to $40,031 thousand, a $33,189 thousand (83%) increase; removed in the newer filing.
- Older filing contained three-month gross profit of $235,141 thousand compared to $119,411 thousand, a $115,730 thousand (97%) increase; removed in the newer filing.
- Older filing contained three-month gross margin of 76.3% compared to 74.9%, a 136 bps increase; removed in the newer filing.
- Older filing described the cost of revenue increase as due to 'higher overall unit shipments and a favorable shift in product mix'; the 'favorable shift in product mix' language is removed in the newer filing.
- Older filing described the gross margin increase as driven by 'a favorable product mix'; removed in the newer filing.
- Older filing contained Research and Development and Sales and Marketing sections for the three months ended March 31, 2026; these sections are removed in the newer filing.
- Reworded:
- The newer filing changes the Overview revenue sentence from 'and to $852.5 million in 2025. Our revenue was $308.4 million for the three months ended March 31, 2026' to 'to $852.5 million in 2025. Our revenue was $700.8 million for the six months ended June 30, 2026'.
- The newer filing removes the word 'and' before 'to $852.5 million in 2025' in the revenue growth sentence: older read '$396.3 million in 2024, and to $852.5 million in 2025'; newer reads '$396.3 million in 2024, to $852.5 million in 2025'.
- The newer filing changes the cost of revenue discussion from 'primarily due to higher overall unit shipments and a favorable shift in product mix' to 'primarily due to higher unit shipments and shift in product mix cost'.
- The newer filing changes the gross margin driver discussion from 'primarily driven by a favorable product mix' to 'primarily driven by a shift in product mix towards lower margin hardware modules, as well as the impact of the Warrants'.
- The newer filing reorders the product demand drivers from 'Scorpio, Aries, and Taurus products' to 'Aries, Scorpio, and Taurus products'.
- Notes:
- The newer filing text provided is truncated at the end, cutting off mid-sentence in the Gross margin discussion and does not include the Research and Development, Sales and Marketing, and subsequent sections, so changes in those later sections cannot be assessed.
- The older filing text provided ends at the Sales and Marketing section and is also truncated, so subsequent sections cannot be compared.
Risk Factors
- Added:
- Newer filing adds a table disclosing that Manuel Alba, Chair of the Board, adopted a Rule 10b5-1 Trading Arrangement on 5/22/2026 covering 1,412,000 shares with an expiration date of 8/31/2027.
- Newer filing adds footnote (1) stating that each trading arrangement marked as a 'Rule 10b5-1 Trading Arrangement' is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act.
- Newer filing adds footnote (2) describing that each trading arrangement permits transactions through the earlier of completion of sales or the date listed, only permits transactions upon expiration of the mandatory cooling-off period, and is scheduled to terminate on the earlier of the expiration date or when all shares are sold, subject to early termination for certain specified events.
- Newer filing adds footnote (3) stating that the shares covered by the trading arrangement include certain shares held by trusts and may be deemed to be indirectly beneficially owned by Manuel Alba.
- Newer filing adds the statement 'Our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, terminated or modified...during the quarterly period covered by this report as described in the table below:' in Item 5.
- Removed:
- Older filing states in Item 5 that during the three months ended March 31, 2026, none of the directors or officers adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading agreement.
- Older filing includes exhibits 10.1, 10.2, 10.3, and 10.4 (Offer Letter with Desmond Lynch, Transition Agreement with Michael Tate, Warrant Agreement with Amazon.com NV Investment Holdings LLC, and Transaction Agreement with Amazon, Inc.) in the exhibit list; these exhibits do not appear in the newer filing's exhibit list.
- Reworded:
- Newer filing replaces the statement that no Rule 10b5-1 or non-Rule 10b5-1 trading arrangements were adopted/terminated/modified during the period with a disclosure table describing a Rule 10b5-1 trading arrangement adoption by Manuel Alba.
- Newer filing's signature date is August 4, 2026, while the older filing's signature date is May 5, 2026.
- Notes:
- The provided texts include portions beyond the Risk Factors section (Items 2-6, exhibits, signatures); changes noted are limited to what appears in the provided excerpts.
- The Risk Factors text itself is identical between the two filings; the differences identified are in the accompanying sections of Part II included in the excerpts.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 99 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 99 sells ($123M) — 5 selling insiders
- Last 180 days · read to 2026-10-040 buys · 368 sells ($630M) — 7 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-02. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ALAB's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for ALAB from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding ALAB as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 50,153,514
- Reported value $24,225,150,349
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ALAB's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ALAB had 8,685,910 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
ALAB had 5.01% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.24 days to cover at the same settlement.
- Reported short interest (shares) 8,685,910
- Short interest (% of shares outstanding) 5.01%
- Prior settlement (shares) 9,033,499
- Reported change -3.85%
- Days to cover (reported) 2.24
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Broadcom (AVGO)
- Marvell Technology (MRVL)
- Texas Instruments (TXN)
- Analog Devices (ADI)
- NVIDIA (NVDA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ALAB vs…
Astera Labs is found in…
Frequently asked questions
What does Astera Labs (ALAB) do?
Astera Labs designs and delivers semiconductor-based connectivity solutions optimized for cloud and AI infrastructure. Its Intelligent Connectivity Platform combines high-speed, mixed-signal hardware—such as retimers, memory controllers, and switches—with a proprietary software suite called COSMOS to manage data, network, and memory bottlenecks in large-scale data centers.
What sector is Astera Labs (ALAB) in?
Astera Labs (ALAB) is classified in the Information Technology sector. Its industry is Semiconductors / Connectivity Solutions. It trades on NASDAQ.
Who are Astera Labs's (ALAB) competitors?
Notable peers of Astera Labs (ALAB) include Broadcom, Marvell Technology, Texas Instruments, Analog Devices and NVIDIA. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in ALAB?
Yes — we hold 2 matched STOCK Act disclosures for ALAB from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Astera Labs (ALAB) overbought or oversold right now?
Astera Labs (ALAB) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 53, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ALAB come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.